1. Inicio
  2. Publicaciones
  3. SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022)

SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022)

Fecha de publicación: Fecha Ahead of Print:

Autores de IDIVAL

Autores ajenos al IDIVAL

  • Garcia-Saenz JA
  • Blancas I
  • Echavarria I
  • Margeli M
  • Moreno F
  • Pernas S
  • Ramon Y Cajal T
  • Ribelles N
  • Bellet M

Unidades

Abstract

Advanced breast cancer represents a challenge for patients and for physicians due its dynamic genomic changes yielding to a resistance to treatments. The main goal is to improve quality of live and survival of the patients through the most appropriate subsequent therapies based on the knowledge of the natural history of the disease. In these guidelines, we summarize current evidence and available therapies for the medical management of advanced breast cancer.

© 2023. The Author(s).

Datos de la publicación

ISSN/ISSNe:
1699-048X, 1699-3055

CLINICAL & TRANSLATIONAL ONCOLOGY  SPRINGER

Tipo:
Practice Guideline
Páginas:
2665-2678
PubMed:
37148499

Citas Recibidas en Web of Science: 14

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • ABC; ADC; Advanced breast cancer; Anti-HER2 therapy; Endocrine therapy; Guidelines; IOT

Compartir